Login to Your Account


Despite Short-Term Revenue Hit, Sanofi Manages Patent Cliff

By Marie Powers
Staff Writer

Wednesday, October 31, 2012
Sanofi SA, which reported third-quarter results last week, placed its pipeline challenges front and center, noting "business [earnings per share] reflects patent expirations."

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription